Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $93.52 million as of February 21, 2025. Its market cap has decreased by -10.51% in one year.

• Market Cap: 93.52M
• Enterprise Value: 171.04M
• 1-Year Change: -10.51%
• Ranking: #4109
• Category: Micro-Cap
• Stock Price: $1.49

Market Cap Chart

Since September 9, 2002, Galectin Therapeutics's market cap has increased from $31.60M to $93.52M, an increase of 195.93%. That is a compound annual growth rate of 4.95%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	93.50M	15.43%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	72.69%
Dec 31, 2002	52.00M	64.56%

View and export this data all the way back to 2002. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.21B
UnitedHealth Group	462.37B
Johnson & Johnson	384.45B
Novo Nordisk	370.84B
AbbVie	354.62B
Abbott Laboratories	230.98B
AstraZeneca	227.07B
Merck & Co.	221.80B